Alector to present at upcoming virtual healthcare conferences

South san francisco, calif., june 03, 2021 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that shehnaaz suliman, m.d., mba, m.phil., president and chief operating officer of alector, will participate in fireside chats at the following upcoming virtual investor conferences:
ALEC Ratings Summary
ALEC Quant Ranking